Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Irwin Naturals Inc (OP: IWINF ) 0.5000 UNCHANGED Last Price Updated: 9:33 AM EDT, Aug 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.5000 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.5000 Today's Range 0.5000 - 0.5000 52wk Range 0.0500 - 0.9544 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Irwin Naturals Sued By East West Bank Over $40M Loan Default August 13, 2024 Irwin Naturals faces a $40M loan lawsuit from East West Bank, leading to Chapter 11 bankruptcy. Explore the implications for the supplements company and its investors. Via Benzinga Topics Bankruptcy Lawsuit Exposures Financial Legal Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Defense Dept. Funds Ketamine Study For PTSD Treatment Via Benzinga Performance YTD +122.42% +122.42% 1 Month +56.79% +56.79% 3 Month +66.67% +66.67% 6 Month +507.53% +507.53% 1 Year -47.60% -47.60% More News Read More Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses November 28, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Via Benzinga Irwin Naturals Launches Trio Of Cannabis Tinctures In California July 28, 2023 Via Benzinga Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY August 28, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 25, 2023 August 25, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA? June 01, 2023 Via Benzinga Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers August 17, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More May 31, 2023 Via Benzinga Marijuana Stock Movers For August 15, 2023 August 15, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA? May 26, 2023 Via Benzinga Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More May 08, 2023 Via Benzinga Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves May 05, 2023 Via Benzinga Cannabis Stock Movers For July 27, 2023 July 27, 2023 Via Benzinga Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue May 03, 2023 Via Benzinga Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector May 01, 2023 Via Benzinga Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Via Benzinga Irwin Naturals Cannabis Products Launch Nationwide In Canada March 24, 2023 Via Benzinga Irwin Naturals Acquires Ketamine Media March 22, 2023 Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Via Benzinga Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal March 16, 2023 Via Benzinga In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend? March 15, 2023 Via Benzinga Here Are The Year's Highest Priced Psychedelics Stocks In US Markets March 06, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.